300 related articles for article (PubMed ID: 27611853)
1. Dosimetric Comparison between Three-Dimensional Magnetic Resonance Imaging-Guided and Conventional Two-Dimensional Point A-Based Intracavitary Brachytherapy Planning for Cervical Cancer.
Ren J; Yuan W; Wang R; Wang Q; Li Y; Xue C; Yan Y; Ma X; Tan L; Liu Z
PLoS One; 2016; 11(9):e0161932. PubMed ID: 27611853
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Dosimetric Influence of Applicator Displacement on 2D and 3D Brachytherapy for Cervical Cancer Treatment.
Wu A; Tang D; Wu A; Liu Y; Qian L; Zhu L
Technol Cancer Res Treat; 2021; 20():15330338211041201. PubMed ID: 34569371
[TBL] [Abstract][Full Text] [Related]
3. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study.
Charra-Brunaud C; Harter V; Delannes M; Haie-Meder C; Quetin P; Kerr C; Castelain B; Thomas L; Peiffert D
Radiother Oncol; 2012 Jun; 103(3):305-13. PubMed ID: 22633469
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
Pobijakova M; Scepanovic D; Paluga M; Fekete M; Mardiak J
Neoplasma; 2018 Mar; 65(3):425-430. PubMed ID: 29788726
[TBL] [Abstract][Full Text] [Related]
5. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
[TBL] [Abstract][Full Text] [Related]
6. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
[TBL] [Abstract][Full Text] [Related]
7. Point A vs. HR-CTV D
Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
[TBL] [Abstract][Full Text] [Related]
8. Comparison of dosimetric parameters in the treatment planning of magnetic resonance imaging-based intracavitary image-guided adaptive brachytherapy with and without optimization using the central shielding technique.
Nishikawa R; Yoshida K; Ebina Y; Omoteda M; Miyawaki D; Ishihara T; Ejima Y; Akasaka H; Satoh H; Kyotani K; Takahashi S; Sasaki R
J Radiat Res; 2018 May; 59(3):316-326. PubMed ID: 29518234
[TBL] [Abstract][Full Text] [Related]
9. Comparison of CT-based volumetric dosimetry with traditional prescription points in the treatment of cervical cancer with PDR brachytherapy.
Lowrey N; Nilsson S; Moutrie Z; Chan P; Cheuk R
J Med Imaging Radiat Oncol; 2015 Oct; 59(5):640-5. PubMed ID: 26223554
[TBL] [Abstract][Full Text] [Related]
10. From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer.
Tanderup K; Nielsen SK; Nyvang GB; Pedersen EM; Røhl L; Aagaard T; Fokdal L; Lindegaard JC
Radiother Oncol; 2010 Feb; 94(2):173-80. PubMed ID: 20138380
[TBL] [Abstract][Full Text] [Related]
11. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV.
Haie-Meder C; Pötter R; Van Limbergen E; Briot E; De Brabandere M; Dimopoulos J; Dumas I; Hellebust TP; Kirisits C; Lang S; Muschitz S; Nevinson J; Nulens A; Petrow P; Wachter-Gerstner N;
Radiother Oncol; 2005 Mar; 74(3):235-45. PubMed ID: 15763303
[TBL] [Abstract][Full Text] [Related]
12. Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses.
Onal C; Arslan G; Topkan E; Pehlivan B; Yavuz M; Oymak E; Yavuz A
J Exp Clin Cancer Res; 2009 Jul; 28(1):95. PubMed ID: 19570212
[TBL] [Abstract][Full Text] [Related]
13. Who Really Benefits from 3D-Based Planning of Brachytherapy for Cervical Cancer?
Ha IB; Jeong BK; Kang KM; Jeong H; Lee YH; Choi HS; Lee JH; Choi WJ; Shin JK; Song JH
J Korean Med Sci; 2018 Apr; 33(18):e135. PubMed ID: 29713255
[TBL] [Abstract][Full Text] [Related]
14. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
[TBL] [Abstract][Full Text] [Related]
15. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.
Pötter R; Haie-Meder C; Van Limbergen E; Barillot I; De Brabandere M; Dimopoulos J; Dumas I; Erickson B; Lang S; Nulens A; Petrow P; Rownd J; Kirisits C;
Radiother Oncol; 2006 Jan; 78(1):67-77. PubMed ID: 16403584
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix.
Zwahlen D; Jezioranski J; Chan P; Haider MA; Cho YB; Yeung I; Levin W; Manchul L; Fyles A; Milosevic M
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1157-64. PubMed ID: 19101097
[TBL] [Abstract][Full Text] [Related]
17. Treatment planning for high dose rate brachytherapy of cervical cancer based on total dose constraints.
Bahadur YA; Constantinescu CT; Hassouna AH; El-Sayed ME
Saudi Med J; 2011 May; 32(5):495-503. PubMed ID: 21556471
[TBL] [Abstract][Full Text] [Related]
18. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer.
Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Furuya S; Tanaka E; Uegaki T; Kuriyama K; Matsumoto H; Yamada S; Ban C
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):765-72. PubMed ID: 19836165
[TBL] [Abstract][Full Text] [Related]
19. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
[TBL] [Abstract][Full Text] [Related]
20. CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters.
Shin KH; Kim TH; Cho JK; Kim JY; Park SY; Park SY; Kim DY; Chie EK; Pyo HR; Cho KH
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):197-204. PubMed ID: 16169676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]